Organization Overview
Alternative names
aldesleukin (Proleukin) (2 trials)
allogeneic blood cells (1 trial)
allogeneic hematopoietic stem cells (Hemacord) (5 trials)
anastrozole (arimidex) (3 trials)
asparaginase (elspar) (1 trial)
autologous hematopoietic stem cells (16 trials)
bevacizumab (avastin) (19 trials)
bicalutamide (casodex) (7 trials)
bleomycin (blenoxane) (7 trials)
bortezomib (velcade) (8 trials)
bupropion (wellbutrin) (1 trial)
buserelin (receptal) (1 trial)
capecitabine (xeloda) (5 trials)
carboplatin (paraplatin) (24 trials)
carfilzomib (kyprolis) (1 trial)
cetuximab (erbitux) (14 trials)
ciprofloxacin (cipro) (1 trial)
cisplatin (platinol) (38 trials)
clofarabine (clolar) (1 trial)
conjugated equine estrogens (Premarin) (2 trials)
cyclophosphamide (cytoxan) (38 trials)
dacarbazine (dtic-dome) (7 trials)
dactinomycin (cosmegen) (1 trial)
daunorubicin (cerubidine) (5 trials)
decitabine (dacogen) (1 trial)
docetaxel (taxotere) (18 trials)
doxorubicin (Doxil) (35 trials)
doxycycline (vibramycin) (1 trial)
erlotinib (tarceva) (4 trials)
estramustine (emcyt) (4 trials)
etoposide (vepesid) (18 trials)
exemestane (aromasin) (1 trial)
Filgrastim (neupogen) (6 trials)
fludarabine (fludara) (5 trials)
fluorouracil (efudex) (26 trials)
flutamide (eulexin) (4 trials)
gemcitabine (gemzar) (19 trials)
gemtuzumab ozogamicin (mylotarg) (2 trials)
goserelin (zoladex) (7 trials)
hydroxyurea (hydrea) (3 trials)
ibandronate (boniva) (1 trial)
idarubicin (idamycin) (1 trial)
isotretinoin (Accutane) (4 trials)
ketoconazole (nizoral) (2 trials)
lenalidomide (revlimid) (6 trials)
leuprolide (lupron) (6 trials)
levamisole (ergamisol) (2 trials)
loperamide (imodium) (1 trial)
mechlorethamine (mustargen) (1 trial)
medroxyprogesterone (provera) (1 trial)
melphalan (alkeran) (5 trials)
mercaptopurine (purinethol) (1 trial)
methylphenidate (ritalin) (1 trial)
mitomycin (mutamycin) (2 trials)
mitoxantrone (novantrone) (2 trials)
n-(4-hydroxyphenyl)all-trans retinamide (2 trials)
naltrexone (revia) (12 trials)
nicotine (nicorette) (2 trials)
nilutamide (nilandron) (1 trial)
octreotide (sandostatin) (4 trials)
oxaliplatin (eloxatin) (12 trials)
paclitaxel (taxol) (42 trials)
pemetrexed (alimta) (5 trials)
rituximab (rituxan) (17 trials)
sargramostim (leukine) (34 trials)
selenomethionine se-75 (1 trial)
sulfamethoxazole (gantanol) (1 trial)
tamoxifen (nolvadex) (7 trials)
temozolomide (temodar) (4 trials)
thalidomide (Thalomid) (2 trials)
topotecan (hycamtin) (3 trials)
tositumomab (Bexxar) (1 trial)
trastuzumab (herceptin) (6 trials)
vinblastine (velban) (9 trials)
vincristine (oncovin) (21 trials)
vinorelbine (navelbine) (2 trials)
12 peptide melanoma vaccine (1 trial)
alemtuzumab (campath) (1 trial)
allogeneic lymphocytes (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
arsenic trioxide (trisenox) (1 trial)
atrasentan hydrochloride (1 trial)
autologous mononuclear stem cell (1 trial)
azacitidine (vidaza) (1 trial)
bendamustine (treanda) (2 trials)
carboxyamidotriazole (1 trial)
denileukin diftitox (ontak) (1 trial)
emepepimut-s (Stimuvax) (1 trial)
epirubicin (ellence) (1 trial)
everolimus (zortress) (1 trial)
flecainide (tambocor) (1 trial)
fowlpox virus vaccine (1 trial)
fulvestrant (faslodex) (1 trial)
gp-100 peptide vaccine (1 trial)
gvax prostate cancer vaccine (1 trial)
ibritumomab tiuxetan (Zevalin) (1 trial)
incomplete freund's adjuvant (2 trials)
mart-1 peptide pulsed dendritic cells (1 trial)
multi-epitope melanoma peptide vaccine (1 trial)
mycophenolate (CellCept) (2 trials)
nelfinavir (viracept) (1 trial)
pentostatin (nipent) (3 trials)
ramucirumab (cyramza) (1 trial)
saquinavir (invirase) (1 trial)
Adenocarcinoma (Phase 3)
Adenocarcinoma, Bronchiolo-Alveolar (Phase 3)
Adenocarcinoma, Clear Cell (Phase 3)
Adenocarcinoma, Mucinous (Phase 3)
Adenocarcinoma of Lung (Phase 3)
Adenoma, Islet Cell (Phase 2)
Amyloidosis (Phase 2)
Anemia (Phase 3)
Anemia, Refractory (Phase 3)
Anus Neoplasms (Phase 3)
Astrocytoma (Phase 3)
Breast Neoplasms (Phase 3)
Breast Neoplasms, Male (Phase 2)
Carcinoid Tumor (Phase 2)
Carcinoma (Phase 3)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Adenosquamous (Phase 3)
Carcinoma, Endometrioid (Phase 3)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Islet Cell (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 3)
Carcinoma, Ovarian Epithelial (Phase 3)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Signet Ring Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 3)
Carcinoma, Verrucous (Phase 2)
Carcinosarcoma (Phase 3)
Central Nervous System Neoplasms (Phase 3)
Chondrosarcoma (Phase 2)
Choriocarcinoma (Phase 3)
Colonic Neoplasms (Phase 3)
Colorectal Neoplasms (Phase 3)
Communicable Diseases (Phase 3)
Cystadenocarcinoma (Phase 3)
Cystadenocarcinoma, Serous (Phase 3)
Diarrhea (Phase 3)
Dysplastic Nevus Syndrome (Phase 2)
Endometrial Neoplasms (Phase 3)
Ependymoma (Phase 2)
Esophageal Neoplasms (Phase 3)
Fatigue (Phase 3)
Fibrosarcoma (Phase 2)
Fowlpox (Phase 2)
Gastrinoma (Phase 2)
Gastrointestinal Neoplasms (Phase 2)
Gastrointestinal Stromal Tumors (Phase 3)
Gestational Trophoblastic Disease (Phase 3)
Glioblastoma (Phase 2)
Glioma (Phase 3)
Glucagonoma (Phase 2)
Head and Neck Neoplasms (Phase 3)
Hemangiopericytoma (Phase 2)
Hodgkin Disease (Phase 3)
Hot Flashes (Phase 3)
Hydatidiform Mole (Phase 3)
Immunoblastic Lymphadenopathy (Phase 2)
Immunoglobulin Light-chain Amyloidosis (Phase 2)
Infections (Phase 3)
Infertility (Phase 3)
Insulinoma (Phase 2)
Kidney Neoplasms (Phase 3)
Laryngeal Diseases (Phase 2)
Laryngeal Neoplasms (Phase 2)
Leiomyosarcoma (Phase 2)
Leukemia (Phase 3)
Leukemia, Erythroblastic, Acute (Phase 3)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 3)
Leukemia, Lymphoid (Phase 3)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Megakaryoblastic, Acute (Phase 3)
Leukemia, Monocytic, Acute (Phase 3)
Leukemia, Myeloid (Phase 3)
Leukemia, Myeloid, Acute (Phase 3)
Leukemia, Myelomonocytic, Acute (Phase 3)
Leukemia, T-Cell (Phase 2)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 3)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 2)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Follicular (Phase 3)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Malignant Carcinoid Syndrome (Phase 2)
Medulloblastoma (Phase 2)
Melanoma (Phase 3)
Meningeal Neoplasms (Phase 2)
Meningioma (Phase 2)
Mesothelioma (Phase 2)
Multiple Myeloma (Phase 3)
Myelodysplastic Syndromes (Phase 3)
Myeloproliferative Disorders (Phase 2)
Nasopharyngeal Carcinoma (Phase 2)
Nasopharyngeal Neoplasms (Phase 2)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Neoplasms, Squamous Cell (Phase 2)
Neoplasms, Unknown Primary (Phase 2)
Nervous System Neoplasms (Phase 3)
Neuralgia (Phase 2)
Neuroendocrine Tumors (Phase 2)
Neurotoxicity Syndromes (Phase 3)
Oligodendroglioma (Phase 3)
Oropharyngeal Neoplasms (Phase 2)
Ovarian Neoplasms (Phase 3)
Pancoast Syndrome (Phase 2)
Pancreatic Neoplasms (Phase 3)
Papilloma (Phase 2)
Papillomavirus Infections (Phase 2)
Paranasal Sinus Neoplasms (Phase 2)
Penile Neoplasms (Phase 2)
Pheochromocytoma (Phase 3)
Plasmablastic Lymphoma (Phase 2)
Plasmacytoma (Phase 3)
Pleural Effusion (Phase 3)
Pleural Effusion, Malignant (Phase 3)
Polycythemia (Phase 2)
Polycythemia Vera (Phase 2)
Precancerous Conditions (Phase 3)
Preleukemia (Phase 3)
Primary Myelofibrosis (Phase 2)
Prostatic Intraepithelial Neoplasia (Phase 3)
Prostatic Neoplasms (Phase 3)
Rectal Neoplasms (Phase 3)
Recurrence (Phase 3)
Rhabdomyosarcoma (Phase 2)
Salivary Gland Neoplasms (Phase 2)
Sarcoma (Phase 3)
Sarcoma, Kaposi (Phase 3)
Small Cell Lung Carcinoma (Phase 3)
Somatostatinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 2)
Stomach Neoplasms (Phase 2)
Syndrome (Phase 3)
Testicular Neoplasms (Phase 3)
Thrombocythemia, Essential (Phase 2)
Thrombocytosis (Phase 2)
Thymoma (Phase 2)
Thymus Neoplasms (Phase 2)
Tongue Neoplasms (Phase 2)
Trophoblastic Neoplasms (Phase 3)
Ureteral Neoplasms (Phase 3)
Urethral Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 3)
Uterine Cervical Neoplasms (Phase 3)
Vaccinia (Phase 2)
Virus Diseases (Phase 2)
Waldenstrom Macroglobulinemia (Phase 2)